drugset / Trial / NCT00431093

Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)

NCT00431093

Phase 4 Completed 570 enrolled Organon and Co
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The present trial is undertaken to compare the effects of Tibolone with a low-dose HRT regimen.

Timeline

Start
2002-11
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 1 mg Oral
Subject Norethindrone Unknown 0.5 mg Oral
Comparator Tibolone Other / unclassified 2.5 mg Oral

Indications

No indication recorded.